The emerging therapy of this peptide represents a exciting breakthrough in the care of type 2 diabetes. Different to existing therapies, tirzepatide targets dual pathways – the GLP-1 hormone and the GIP hormone – https://tirzepatidepeptide471928.bligblogging.com/42741113/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment